CyBio and Promega sign Collaboration Agreement for the Development of High-Throughput Applications

21-Jun-2007

CyBio AG and Promega Corporation have signed a long-term collaboration agreement for the joint development and co-marketing of applications on CyBio's liquid handling instruments. CyBio maintains the co-operation with a partner who develops and distributes worldwide highly specific reagents, kits and assays for gene, protein and cell analysis. The co-operation's goal is to jointly develop validated application protocols and to market those for high-throughput screening processes in drug development and life science research.

One topic of the collaboration focuses on the automation of Promega's cell-based multiplex-assays. Such assays deliver increased data quality in toxicity studies of potential drug compounds at lower costs.

Other news from the department business & finance

Most read news

More news from our other portals

Fighting cancer: latest developments and advances

See the theme worlds for related content

Topic World Cell Analysis

Cell analyse advanced method allows us to explore and understand cells in their many facets. From single cell analysis to flow cytometry and imaging technology, cell analysis provides us with valuable insights into the structure, function and interaction of cells. Whether in medicine, biological research or pharmacology, cell analysis is revolutionizing our understanding of disease, development and treatment options.

5+ products
5 whitepaper
5+ brochures
View topic world

Topic World Cell Analysis

Cell analyse advanced method allows us to explore and understand cells in their many facets. From single cell analysis to flow cytometry and imaging technology, cell analysis provides us with valuable insights into the structure, function and interaction of cells. Whether in medicine, biological research or pharmacology, cell analysis is revolutionizing our understanding of disease, development and treatment options.

5+ products
5 whitepaper
5+ brochures